EMP2 and neoplasm: In vitro studies, immunohistochemistry in tumor specimens, and correlation analyses in tissue specimens confirmed that genistein increased CREB1, pCREB1(S133) and EMP2 protein levels, and that the EMP2 was transactivated by pCREB1(S133).